Home Featured Page 174

Featured

Latest

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human Psyche

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples Therapy

Taking the Helm at Helus: A Brief Q&A With New CEO Michael Cola

The Psychedelic Practitioner Issue 3: Dosing

PT321 – Lyle Maxson – Virtual Reality, Biofeedback, and Digital Therapeutics:...

Psychedelic Bulletin #103 – MAPS Phase 3 Trial On Schedule;...

PT320 – Anne Philippi – The New Health Club, Intergenerational Trauma,...

PT319 – Kole – Activism and Trust: A Cautionary Tale From...

Psychedelic Bulletin #102 – Our Analysis of MindMed’s LSD for Anxiety...

PT318 – Del Jolly, Rashad Evans, and Jake Plummer – Functional...

Update on the Fight for Religious Liberties in Oregon

Psychedelic Research Bulletin: April 2022

PT317 – Jason Grechanik – Ancient Wisdom, Plant Dietas, and The...

1...173174175...308 Page 174 of 308

EDITOR PICKS

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human...

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human Psyche

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples Therapy

Taking the Helm at Helus: A Brief Q&A With New CEO Michael Cola

The Psychedelic Practitioner Issue 3: Dosing

PT321 – Lyle Maxson – Virtual Reality, Biofeedback, and Digital Therapeutics:...

Psychedelic Bulletin #103 – MAPS Phase 3 Trial On Schedule;...

PT320 – Anne Philippi – The New Health Club, Intergenerational Trauma,...

PT319 – Kole – Activism and Trust: A Cautionary Tale From...

DO-Why? The Story of DOI

Psychedelic Bulletin #102 – Our Analysis of MindMed’s LSD for Anxiety...

PT318 – Del Jolly, Rashad Evans, and Jake Plummer – Functional...

Update on the Fight for Religious Liberties in Oregon

Psychedelic Research Bulletin: April 2022

PT317 – Jason Grechanik – Ancient Wisdom, Plant Dietas, and The...

EDITOR PICKS

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human...

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY